# ABACAVIR SULFATE AND LAMIVUDINE
> **ANDA208990** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2018-11-15
## Drug
- **FDA Application Number:** ANDA208990
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR SULFATE AND LAMIVUDINE
- **Generic name:** Abacavir Sulfate
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ZYDUS PHARMS
- **First approval:** 2018-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208990)
---
*MORVS · CC0 1.0*